SRTA Earnings Date: Nov 3, 2026 (Estimated) — Strata Critical Medical, Inc.
NASDAQ · Industrials · Airlines
Updated
When is SRTA's next earnings date?
Strata Critical Medical, Inc. (SRTA) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.01 on revenue of $72.7M.
How did SRTA do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Strata Critical Medical, Inc. posted EPS of -$0.12 versus the -$0.04 estimate, a miss of 200.0%. Revenue was $72.5M against a $66.9M estimate. The stock's 1-day post-earnings move was +0.4%.
How much does SRTA stock move after earnings?
SRTA beat EPS estimates in 4 of its last 8 reported quarters. Over the last 4 reports the stock moved an average of 6.8% (up or down) in the day after earnings.
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | -0.04 | -0.12 | -200.00% | $72.5M | ❌ Miss | +0.36% | +7.03% | -3.24% |
| 2026-05-06 | Q1 2026 | -0.04 | 0.03 | +175.00% | $67.4M | ✅ Beat | +10.58% | +13.49% | +29.88% |
| 2026-03-03 | Q4 2025 | -0.04 | -0.06 | -50.00% | $66.8M | ❌ Miss | +6.90% | +1.78% | -6.90% |
| 2025-11-10 | Q3 2025 | -0.02 | -0.12 | -500.00% | $49.3M | ❌ Miss | +9.48% | +8.13% | +2.48% |
| 2022-11-10 | -0.14 | -0.13 | — | $45.7M | ✅ Beat | — | — | — | |
| 2022-08-09 | -0.13 | -0.09 | — | $35.6M | ✅ Beat | — | — | — | |
| 2022-05-10 | -0.19 | -0.19 | — | $26.6M | ➖ Inline | — | — | — | |
| 2022-02-10 | -0.21 | -0.13 | — | $24.6M | ✅ Beat | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $72.5M total
| Segment | Share | Revenue | YoY | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 |
|---|---|---|---|---|---|---|---|
| Logistics | 66.5% | $48.2M | — | — | — | — | — |
| Clinical | 33.5% | $24.3M | — | — | — | — | — |
By region
Q2 FY25 · $70.8M total
| Segment | Share | Revenue | YoY | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 88.2% | $62.4M | +7.7% | $42.1M | $45.3M | $58.0M | $63.3M |
| Non-US | 11.8% | $8.4M | -16.0% | $5.4M | $6.2M | $9.9M | $11.6M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.